Skip to search formSkip to main contentSkip to account menu

defibrotide sodium

A polydeoxyribonucleotide with antithrombotic, thrombolytic, and fibrinolytic properties. Defibrotide induces the release of prostaglandin 12 and… 
National Institutes of Health

Related topics

Related topics

2 relations

Narrower (1)

Defitelio

Broader (1)

defibrotide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Novel Drugs Passed Muster in 2016.
  • R. Voelker
  • Journal of the American Medical Association (JAMA…
  • 2017
  • Corpus ID: 36943106
Review
2017
Review
2017
Inspections Turn up Insects, Mold in Drug Compounding Facilities.
  • R. Voelker
  • Journal of the American Medical Association (JAMA…
  • 2017
  • Corpus ID: 28699641
Novel Drugs Passed Muster in 2016 During 2016, the FDA’s Center for Drug Evaluation and Research (CDER) approved 22 novel drugs… 
2016
2016
Defitelio (Defibrotide Sodium): FDA Approved for Patients with Hepatic Veno-Occlusive Disease
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)